Iżrael - Ebrajk - Ministry of Health

glaxo smith kline (israel) ltd - orlistat 60 mg - capsules - orlistat - for weight loss in overweight adults, 18 years and older, when used along with a reduced - calorie and low-fat diet.

Iżrael - Ebrajk - Ministry of Health

teva pharmaceutical indust.ltd - alfacalcidol 0.5 mcg - capsules - alfacalcidol - renal bone disease . hypoparathyroidisim. rickets and osteomalacia. osteoporosis. primary and tertiary hyperparathyroidism. neonatal hypocalcemia.

Iżrael - Ebrajk - Ministry of Health

rafa laboratories ltd - acetylsalicylic acid 25 mg; dipyridamole 200 mg - capsules - acetylsalicylic acid - secondary prevention of ischaemic strokes and transient ischaemic attacks (tia).

Iżrael - Ebrajk - Ministry of Health

glaxo smith kline (israel) ltd - isosorbide-5-mononitrate 50 mg - capsules - isosorbide mononitrate - for the prophylaxis of angina pectoris.

Iżrael - Ebrajk - Ministry of Health

nutrition consumer health - monoxerutin 300 mg - capsules - monoxerutin - for the adjunctive treatment of varicose veins in all stages.

Iżrael - Ebrajk - Ministry of Health

rafa laboratories ltd - ramipril 2.5 mg - capsules - ramipril - hypertension congestive heart failure reduction of mortality in patients after mi with left ventricular dysfunction. for reducing the risk of myocardial infarction stroke cardiovascular death or need for revascularization procedures in patients over 55 years or more who have clinical evidence of cardiovascular disease (previous mi unstable angina or multivessel cabg or multivessel ptca) stroke or peripheral vascular disease. also for reducing the risk of myocardial infarction stroke cardiovascular death or need for revascularization procedures in diabetic patients of 55 years or more who have one or more of the following clinical findings : hypertension (systolic blood pressure > 160 mmhg or diastolic pressure > 90 mmhg) high total cholesterol (>5.2 mmol/l) low hdl ( <0.9 mmol/l) current smoker known microalbuminuria clinical evidence of previous vascular disease. prevention of progressive renal failure in patients suffering from impaired renal function.

Iżrael - Ebrajk - Ministry of Health

rafa laboratories ltd - ramipril 5 mg - capsules - ramipril - hypertension congestive heart failure reduction of mortality in patients after mi with left ventricular dysfunction. for reducing the risk of myocardial infarction stroke cardiovascular death or need for revascularization procedures in patients over 55 years or more who have clinical evidence of cardiovascular disease (previous mi unstable angina or multivessel cabg or multivessel ptca) stroke or peripheral vascular disease. also for reducing the risk of myocardial infarction stroke cardiovascular death or need for revascularization procedures in diabetic patients of 55 years or more who have one or more of the following clinical findings : hypertension (systolic blood pressure > 160 mmhg or diastolic pressure > 90 mmhg) high total cholesterol (>5.2 mmol/l) low hdl ( <0.9 mmol/l) current smoker known microalbuminuria clinical evidence of previous vascular disease. prevention of progressive renal failure in patients suffering from impaired renal function.

Iżrael - Ebrajk - Ministry of Health

rafa laboratories ltd - ramipril 1.25 mg - capsules - ramipril - hypertension congestive heart failure reduction of mortality in patients after mi with left ventricular dysfunction. for reducing the risk of myocardial infarction stroke cardiovascular death or need for revascularization procedures in patients over 55 years or more who have clinical evidence of cardiovascular disease (previous mi unstable angina or multivessel cabg or multivessel ptca) stroke or peripheral vascular disease. also for reducing the risk of myocardial infarction stroke cardiovascular death or need for revascularization procedures in diabetic patients of 55 years or more who have one or more of the following clinical findings : hypertension (systolic blood pressure > 160 mmhg or diastolic pressure > 90 mmhg) high total cholesterol (>5.2 mmol/l) low hdl ( <0.9 mmol/l) current smoker known microalbuminuria clinical evidence of previous vascular disease. prevention of progressive renal failure in patients suffering from impaired renal function.

Iżrael - Ebrajk - Ministry of Health

novartis pharma services ag - fluvastatin as sodium 20 mg - capsules - fluvastatin - reduction of elevated levels of total cholesterol, ldl cholesterol, apolipoprotein b and triglycerides and increase of hdl cholesterol in patients with primary hypercholesterolemia and primary mixed dyslipidemia (fredrickson types iia and iib) in whom dietary measures have proved insufficiently effective.

Iżrael - Ebrajk - Ministry of Health

novartis pharma services ag - fluvastatin as sodium 40 mg - capsules - fluvastatin - reduction of elevated levels of total cholesterol, ldl cholesterol, apolipoprotein b and triglycerides and increase of hdl cholesterol in patients with primary hypercholesterolemia and primary mixed dyslipidemia (fredrickson types iia and iib) in whom dietary measures have proved insufficiently effective.